ArticleJournal of Cancer2017

Nab-paclitaxel as First Line Treatment for NSCLC in Elderly Patients More Than 75 Years Old.

Paul Zarogoulidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.